当前位置:首页 - 行情中心 - 葵花药业(002737) - 财务分析 - 现金流量表

葵花药业

(002737)

  

流通市值:160.60亿  总市值:160.60亿
流通股本:5.84亿   总股本:5.84亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,515,811,304.346,164,389,417.614,271,571,617.813,197,778,454.44
收到其他与经营活动有关的现金40,744,852.2133,400,461.269,609,266.3251,890,618.31
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,556,556,156.546,297,789,878.814,341,180,884.133,249,669,072.75
购买商品、接受劳务支付的现金707,694,982.682,455,415,914.621,769,578,575.781,272,022,751.89
支付给职工以及为职工支付的现金170,036,175.78611,932,237.04463,855,832.94323,679,997.91
支付的各项税费176,112,512.09723,412,942.58542,539,631.27416,509,393.73
支付其他与经营活动有关的现金298,421,913.041,617,340,889.411,177,686,306.46861,678,964.49
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,352,265,583.595,408,101,983.653,953,660,346.452,873,891,108.02
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额204,290,572.95889,687,895.16387,520,537.68375,777,964.73
二、投资活动产生的现金流量:
收回投资收到的现金1,000,000,0002,270,000,0001,670,000,0001,470,000,000
取得投资收益收到的现金20,817,239.7333,612,581.2826,585,555.3224,859,867.34
处置固定资产、无形资产和其他长期资产收回的现金净额-4,051,114.911,203,1001,115,100
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,020,817,239.732,307,663,696.191,697,788,655.321,495,974,967.34
购建固定资产、无形资产和其他长期资产支付的现金13,985,381.42149,164,927.9108,817,283.2281,758,019.75
投资支付的现金-2,122,300,0001,620,357,5001,220,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计13,985,381.422,271,464,927.91,729,174,783.221,301,758,019.75
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额1,006,831,858.3136,198,768.29-31,386,127.9194,216,947.59
三、筹资活动产生的现金流量:
取得借款收到的现金-10,000,00010,000,00010,000,000
收到其他与筹资活动有关的现金-4,432,734.26--
筹资活动现金流入平衡项目-000
筹资活动现金流入小计-14,432,734.2610,000,00010,000,000
偿还债务支付的现金-420,000,000420,000,000390,000,000
分配股利、利润或偿付利息支付的现金92,263.9626,791,868.06621,083,399.09617,505,746.01
其中:子公司支付给少数股东的股利、利润-38,282,840.2531,276,272.231,276,272.2
支付其他与筹资活动有关的现金923,528.666,471,110.21--
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,015,792.561,053,262,978.271,041,083,399.091,007,505,746.01
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,015,792.56-1,038,830,244.01-1,031,083,399.09-997,505,746.01
四、汇率变动对现金及现金等价物的影响-134,377.44231,536.1791,198.88252,535.83
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额1,209,972,261.26-112,712,044.39-674,857,790.43-427,258,297.86
加:期初现金及现金等价物余额2,285,705,205.892,398,417,250.282,398,417,250.282,398,417,250.28
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,495,677,467.152,285,705,205.891,723,559,459.851,971,158,952.42
补充资料:
净利润-1,164,938,619.77-678,906,120.66
资产减值准备--1,574,895.25-3,048,479.46
固定资产和投资性房地产折旧-145,333,662.22-90,323,168.56
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-145,333,662.22-90,323,168.56
无形资产摊销-29,487,172.38-15,046,942.47
长期待摊费用摊销-2,047,629.88-917,256.37
处置固定资产、无形资产和其他长期资产的损失--3,230,614.33-907,650.19
固定资产报废损失-482,198.61--
公允价值变动损失-16,388,444.95-15,372,824.07
财务费用-6,051,674.96-4,027,884.25
投资损失--46,963,767.59--24,698,446.29
递延所得税--4,690,346.18-4,961,695.12
其中:递延所得税资产减少--2,408,911.86-4,497,831.68
递延所得税负债增加--2,281,434.32-463,863.44
存货的减少--241,473,064.3--221,339,519.44
经营性应收项目的减少-77,043,891.06--22,139,703.18
经营性应付项目的增加--286,200,476.59--172,562,487.67
其他-25,664,565.81--
现金的期末余额-2,285,705,205.89-1,971,158,952.42
减:现金的期初余额-2,398,417,250.28-2,398,417,250.28
公告日期2024-04-262024-04-262023-10-262023-08-25
审计意见(境内)标准无保留意见
TOP↑